
Ophirex to produce snake venom inhibitor for LSTM study
Public benefit corporation Ophirex has entered an agreement to produce a snake venom inhibitor for the Liverpool School of Tropical Medicine (LSTM). Marimastat is an inhibitor of snake venom metalloproteinases, a major snake venom toxin which plays a primary role in the digestion of tissues, leading to swelling, necrosis and internal… Read More


